Ptc Therapeutics (PTCT) Short-term Investments (2013 - 2026)

Ptc Therapeutics' Short-term Investments history runs 14 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Short-term Investments rose 93.52% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 93.52% YoY), while the FY2025 annual figure was $960.7 million, up 166.88% from the prior year.
• Short-term Investments was $1.1 billion for Q1 2026 at Ptc Therapeutics, up from $960.7 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $1.1 billion in Q1 2026 to a low of $118.8 million in Q1 2023.
• Historically, Short-term Investments has averaged $467.2 million across 5 years, with a median of $360.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Short-term Investments slumped 77.58% in 2022, then jumped 275.89% in 2024.
• A 5-year view of Short-term Investments shows it stood at $130.9 million in 2022, then jumped by 116.04% to $282.7 million in 2023, then climbed by 27.32% to $360.0 million in 2024, then jumped by 166.88% to $960.7 million in 2025, then climbed by 10.18% to $1.1 billion in 2026.
• The last three Short-term Investments figures came in at $1.1 billion (Q1 2026), $960.7 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.